Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR-T cell therapy in multiple myeloma: Current limitations and potential strategies
Xiaomin Zhang, Hui Zhang, Huixuan Lan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma
Naresh Bumma, Joshua Richter, Sundar Jagannath, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 22, pp. 2702-2712
Open Access | Times Cited: 18
CAR‑T cell therapy: A breakthrough in traditional cancer treatment strategies (Review)
Dahua Sun, Xiang Shi, Sanyan Li, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 17
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
CAR-T cell therapy: Where are we now, and where are we heading?
Jiayi Wang, Liang Wang
Blood Science (2023) Vol. 5, Iss. 4, pp. 237-248
Open Access | Times Cited: 25
Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives
Jingjing Pu, Ting Liu, Xuzhen Wang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
Dian Xiong, Lu Zhang, Zhi‐Jun Sun
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 20
Nanotechnology-based in situ cancer vaccines: Mechanisms, design, and recent advances
Gaoli Niu, Hong Wang, Yanhong Zhai, et al.
Nano Today (2024) Vol. 56, pp. 102286-102286
Closed Access | Times Cited: 7
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
Bruno Almeida Costa, Jessica Flynn, Noriko Nishimura, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Let-7 enhances murine anti-tumor CD8 T cell responses by promoting memory and antagonizing terminal differentiation
Alexandria C. Wells, Kaito A. Hioki, Constance C Angelou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma
S. Yuan, Ying Chen, Huasheng Liu
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access | Times Cited: 5
Efficient combination of radiotherapy and CAR-T – A systematic review
Wojciech Szlasa, Aleksandra Sztuder, Agnieszka Kaczmar-Dybko, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116532-116532
Open Access | Times Cited: 5
Approved CAR-T therapies have reproducible efficacy and safety in clinical practice
Daniel Goyco Vera, Hiral Waghela, Mohamed Nuh, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder
Qiusui Mai, Bailin He, Shikai Deng, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma
Shlomit Kfir‐Erenfeld, Nathalie Asherie, Eyal Lebel, et al.
Blood Advances (2024) Vol. 8, Iss. 15, pp. 4077-4088
Closed Access | Times Cited: 4
Mechanisms for resistance to BCMA-targeted immunotherapies in multiple myeloma
Tingting Yue, Yue Sun, Yun Dai, et al.
Blood Reviews (2025), pp. 101256-101256
Closed Access
New therapies to treat cardiac amyloidosis
O.T.D. Nguyen, Daniel Kamna, Ahmad Masri
Current Opinion in Cardiology (2025) Vol. 40, Iss. 2, pp. 98-106
Closed Access
Antitumor Research Based on Drug Delivery Carriers: Reversing the Polarization of Tumor-Associated Macrophages
Xinyu Cao, Shen Wan, Bingyu Wu, et al.
Molecular Pharmaceutics (2025)
Closed Access
CAR T-cell Therapy Landscape in Pediatric, Adolescent and Young Adult Oncology - A Comprehensive Analysis of Clinical Trials
David A Martínez-Gamboa, Rhea Hans, Eider Moreno-Cortes, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 209, pp. 104648-104648
Closed Access
Targeting BCMA in multiple myeloma: designs, challenges, and future directions
Yi Hu, Yuetao Xie, Xiaodong Wang, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Multiple Myeloma Insights from Single-Cell Analysis: Clonal Evolution, the Microenvironment, Therapy Evasion, and Clinical Implications
Sihong Li, Jiahui Liu, Madeline Peyton, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 653-653
Open Access
Clinical Proof-of-Concept of a Non-Gene Editing Technology Using miRNA-Based shRNA to Engineer Allogeneic CAR T-Cells
Caroline Lonez, Jennifer Bolsée, Fanny Huberty, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1658-1658
Open Access
CAR‐T cells in the treatment of multiple myeloma: an encouraging cell therapy
Tong Yu, Jianhang Jiao, Minfei Wu
Frontiers in Immunology (2025) Vol. 16
Open Access
Targeted Therapy: New Targets, Prospects and Clinical Use
Viktoriya R. Kuryanova, Feruza B. Guseinova, Aigerim E. Nurkeldina, et al.
Russian Journal of Oncology (2025)
Open Access
Strategies for salvage therapy post CAR-T therapy failure in refractory/relapsed multiple myeloma patients
Chao Min, Xiong Zhong, Yue Cui, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Mechanistic Study of Cancer Drug Delivery: Current Techniques, Limitations, and Future Prospects
Saiqa Imtiaz, Umme Tamanna Ferdous, Alexis Nizela, et al.
European Journal of Medicinal Chemistry (2025) Vol. 290, pp. 117535-117535
Open Access
Page 1 - Next Page

Scroll to top